ArticleCancer research2015

Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.

Anil Shanker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.